vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.
Virtu Financial, Inc. is the larger business by last-quarter revenue ($1.1B vs $829.0M, roughly 1.3× Acadia Healthcare Company, Inc.). Virtu Financial, Inc. runs the higher net margin — 31.6% vs 0.5%, a 31.1% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (30.7% vs 7.5%). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (25.7% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
ACHC vs VIRT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $1.1B |
| Net Profit | $4.5M | $346.6M |
| Gross Margin | — | — |
| Operating Margin | — | 37.4% |
| Net Margin | 0.5% | 31.6% |
| Revenue YoY | 7.5% | 30.7% |
| Net Profit YoY | -50.8% | 82.8% |
| EPS (diluted) | $0.05 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $1.1B | ||
| Q4 25 | $821.5M | $969.9M | ||
| Q3 25 | $851.6M | $824.8M | ||
| Q2 25 | $869.2M | $999.6M | ||
| Q1 25 | $770.5M | $837.9M | ||
| Q4 24 | $774.2M | $834.3M | ||
| Q3 24 | $815.6M | $706.8M | ||
| Q2 24 | $796.0M | $693.0M |
| Q1 26 | $4.5M | $346.6M | ||
| Q4 25 | $-1.2B | $139.9M | ||
| Q3 25 | $36.2M | $77.6M | ||
| Q2 25 | $30.1M | $151.2M | ||
| Q1 25 | $8.4M | $99.7M | ||
| Q4 24 | $32.6M | $94.1M | ||
| Q3 24 | $68.1M | $60.0M | ||
| Q2 24 | $78.5M | $66.6M |
| Q1 26 | — | 37.4% | ||
| Q4 25 | -142.4% | 35.4% | ||
| Q3 25 | 4.7% | 21.8% | ||
| Q2 25 | 5.8% | 34.7% | ||
| Q1 25 | 1.7% | 26.7% | ||
| Q4 24 | 4.9% | 24.3% | ||
| Q3 24 | 12.1% | 20.8% | ||
| Q2 24 | 13.4% | 22.4% |
| Q1 26 | 0.5% | 31.6% | ||
| Q4 25 | -143.3% | 14.4% | ||
| Q3 25 | 4.3% | 9.4% | ||
| Q2 25 | 3.5% | 15.1% | ||
| Q1 25 | 1.1% | 11.9% | ||
| Q4 24 | 4.2% | 11.3% | ||
| Q3 24 | 8.4% | 8.5% | ||
| Q2 24 | 9.9% | 9.6% |
| Q1 26 | $0.05 | $1.99 | ||
| Q4 25 | $-12.98 | $1.54 | ||
| Q3 25 | $0.40 | $0.86 | ||
| Q2 25 | $0.33 | $1.65 | ||
| Q1 25 | $0.09 | $1.08 | ||
| Q4 24 | $0.36 | $1.03 | ||
| Q3 24 | $0.74 | $0.64 | ||
| Q2 24 | $0.85 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $973.2M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $2.2B |
| Total Assets | $5.5B | $25.1B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $973.2M | ||
| Q4 25 | $133.2M | $1.1B | ||
| Q3 25 | $118.7M | $707.9M | ||
| Q2 25 | $131.4M | $752.1M | ||
| Q1 25 | $91.2M | $723.6M | ||
| Q4 24 | $76.3M | $872.5M | ||
| Q3 24 | $82.1M | $701.4M | ||
| Q2 24 | $77.2M | $684.8M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $2.0B | ||
| Q3 25 | $2.3B | $2.0B | ||
| Q2 25 | $2.3B | $1.7B | ||
| Q1 25 | $2.2B | $1.7B | ||
| Q4 24 | $2.0B | $1.7B | ||
| Q3 24 | $1.9B | $1.7B | ||
| Q2 24 | $1.8B | $1.7B |
| Q1 26 | $2.0B | $2.2B | ||
| Q4 25 | $1.9B | $1.6B | ||
| Q3 25 | $3.1B | $1.5B | ||
| Q2 25 | $3.1B | $1.4B | ||
| Q1 25 | $3.0B | $1.3B | ||
| Q4 24 | $3.1B | $1.3B | ||
| Q3 24 | $3.0B | $1.2B | ||
| Q2 24 | $3.0B | $1.2B |
| Q1 26 | $5.5B | $25.1B | ||
| Q4 25 | $5.5B | $20.2B | ||
| Q3 25 | $6.4B | $21.3B | ||
| Q2 25 | $6.3B | $19.3B | ||
| Q1 25 | $6.1B | $17.5B | ||
| Q4 24 | $6.0B | $15.4B | ||
| Q3 24 | $5.9B | $14.4B | ||
| Q2 24 | $5.7B | $13.9B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 1.29× | ||
| Q3 25 | 0.74× | 1.40× | ||
| Q2 25 | 0.74× | 1.24× | ||
| Q1 25 | 0.72× | 1.33× | ||
| Q4 24 | 0.64× | 1.39× | ||
| Q3 24 | 0.62× | 1.41× | ||
| Q2 24 | 0.62× | 1.41× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $518.4M | ||
| Q3 25 | $73.2M | $-68.7M | ||
| Q2 25 | $133.5M | $62.8M | ||
| Q1 25 | $11.5M | $15.0M | ||
| Q4 24 | $116.7M | $599.0M | ||
| Q3 24 | $163.1M | $112.1M | ||
| Q2 24 | $171.1M | $490.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $495.6M | ||
| Q3 25 | $-63.0M | $-76.7M | ||
| Q2 25 | $-34.2M | $57.6M | ||
| Q1 25 | $-163.2M | $9.2M | ||
| Q4 24 | $-86.8M | $586.6M | ||
| Q3 24 | $-27.1M | $106.2M | ||
| Q2 24 | $16.9M | $486.9M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 51.1% | ||
| Q3 25 | -7.4% | -9.3% | ||
| Q2 25 | -3.9% | 5.8% | ||
| Q1 25 | -21.2% | 1.1% | ||
| Q4 24 | -11.2% | 70.3% | ||
| Q3 24 | -3.3% | 15.0% | ||
| Q2 24 | 2.1% | 70.3% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 2.4% | ||
| Q3 25 | 16.0% | 1.0% | ||
| Q2 25 | 19.3% | 0.5% | ||
| Q1 25 | 22.7% | 0.7% | ||
| Q4 24 | 26.3% | 1.5% | ||
| Q3 24 | 23.3% | 0.8% | ||
| Q2 24 | 19.4% | 0.6% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.71× | ||
| Q3 25 | 2.02× | -0.89× | ||
| Q2 25 | 4.43× | 0.42× | ||
| Q1 25 | 1.37× | 0.15× | ||
| Q4 24 | 3.58× | 6.37× | ||
| Q3 24 | 2.39× | 1.87× | ||
| Q2 24 | 2.18× | 7.37× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
VIRT
| Trading income, net | $789.1M | 72% |
| Commissions, net and technology services | $186.6M | 17% |
| Other | $119.6M | 11% |
